NuGene International has introduced a reformulated variant of its hair fortifying serum Revellus to haircare buyers and salons. Formulated with the firm's proprietary stem cell technology, the serum is claimed to aid vitality of the scalp and make hair appear fuller, thicker, and voluminous. The serum is formulated using Human Stem Cell Derived (HSCD) proteins, derived from the company's patent pending adipose-derived stem cell culture process, and a blend of antioxidants, natural extracts, and peptides. The resulting formulation is claimed to address nutrient needs of the hair to revive scalp and nourish follicles for a volumising and young appearance. Revellus is also claimed to be free of fragrances, colour additives, parabens, sulfates, propylene glycol, and phthalates.
Livento Group, Inc. is engaged in specializing in the acquisition and development of companies with disruptive business models in the film, content, and technology sectors. The Company operates through its subsidiary, BOXO Productions Inc., a film and television production company, which produces and funds content across a range of genres. The Company operates through two divisions: BOXO Productions, which is engaged in captivating movie production, and Robotics & AI, which is establishing advancements in artificial intelligence. It has developed a software called Elisee that can capture large amounts of data and create predictive behavior based on client inputs that assists the client in establishing its investment portfolio. Elisee uses algorithms that read market data and neurological network abilities to determine the path forward and make ongoing corrections over time.
LIVENTO GROUP, INC. 
